炎症性肠病合并非酒精性脂肪性肝病的经济负担及危险因素

The economic burden and risk factors in inflammatory bowel disease with nonalcoholic fatty liver disease

非酒精性脂肪性肝病(NAFLD)是一种影响约1/4普通人群的疾病,已成为我国及西方国家第一大慢性肝病,造成了巨大的医疗和经济负担。炎症性肠病(IBD)患者中,NAFLD的患病率估计高达40%,包括溃疡性结肠炎和克罗恩病。主要介绍IBD患者中合并NAFLD的现状与经济负担、危险因素评估,并对该类疾病进行总结与展望,以期为未来该领域的进一步研究奠定基础。

Nonalcoholic fatty liver disease(NAFLD)is a disease affecting about a quarter of the general population and has become the most important chronic liver disease in China and Western countries,causing huge medical and economic burdens.The prevalence rate of NAFLD is estimated to be as high as 40%in patients with inflammatory bowel diseases(IBD)such as ulcerative colitis and Crohn’s disease.This article mainly introduces the current status,economic burden,and risk factors for NAFLD in IBD patients and summarizes the current status and prospects of such diseases,in order to lay a foundation for further research in this field.